Ave Mori
Impact in
-
- Advanced Breast Cancer Therapies
-
- Breast Cancer Treatment Studies
Papers in
-
- Advanced Breast Cancer Therapies 16
- Oncology 7
- Colorectal Cancer Treatments and Studies 5
- Pancreatic and Hepatic Oncology Research 1
- Cancer survivorship and care 1
- Co-authors
- Dongrui Ray Lu (15 shared papers)Richard S. Finn (12 shared papers)Karen A. Gelmon (12 shared papers)Veronique C Dieras (10 shared papers)Hope S. Rugo (11 shared papers)Eric Roland Gauthier (9 shared papers)Johannes Ettl (9 shared papers)Shrividya S. Iyer (7 shared papers)
- Journals
- Annals of Oncology (6 papers)Cancer Chemotherapy and Pharmacology (2 papers)The Oncologist (2 papers)European Journal of Cancer (2 papers)The Breast (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Ave Mori
21 papers receiving 919 citations
Ave Mori's Hit Papers
Peers
Comparison fields: 5 of 50
- Pulmonary and Respiratory Medicine 687
- Cancer Research 108
- Oncology 150
- Internal Medicine 6
- Pharmacology 18
Countries citing papers authored by Ave Mori
This map shows the geographic impact of Ave Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ave Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ave Mori more than expected).
Fields of papers citing papers by Ave Mori
This network shows the impact of papers produced by Ave Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ave Mori. The network helps show where Ave Mori may publish in the future.
Co-authors
The 25 scholars most cited alongside Ave Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up Hit paper breakdown → | 2019 | 340 |
| 2 | 2018 | 127 | |
| 3 | 2018 | 80 | |
| 4 | 2018 | 76 | |
| 5 | 2019 | 64 | |
| 6 | 2019 | 59 | |
| 7 | 2021 | 48 | |
| 8 | 1993 | 43 | |
| 9 | Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer. | 1995 | 29 |
| 10 | 2019 | 26 | |
| 11 | 1993 | 10 | |
| 12 | 2019 | 10 | |
| 13 | 2016 | 7 | |
| 14 | 2017 | 7 | |
| 15 | 1995 | 5 | |
| 16 | In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. | 1995 | 5 |
| 17 | 2000 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2017 | 4 | |
| 20 | 2017 | 3 |
About Ave Mori
Ave Mori is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Immunology and Molecular Biology, having authored 23 papers that have together received 957 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (16 papers), Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (1 paper), Cancer survivorship and care (1 paper), Cancer therapeutics and mechanisms (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (687 citations), Cancer Research (108 citations), Oncology (150 citations), Internal Medicine (6 citations) and Pharmacology (18 citations). Ave Mori has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Dongrui Ray Lu, Richard S. Finn, Karen A. Gelmon, Veronique C Dieras, Hope S. Rugo, Eric Roland Gauthier, Johannes Ettl, Shrividya S. Iyer, Cynthia Huang Bartlett and Nadia Harbeck. Their work appears in journals such as Annals of Oncology, Cancer Chemotherapy and Pharmacology, The Oncologist, European Journal of Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.